What’s the Deal With Green Thumb Stock?

Investors in Green Thumb Industries (TSXV:GTII) certainly have a lot to consider after some pretty intriguing recent allegations.

| More on:
Person Hands Opening Mailbox To Remove Newspaper

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Green Thumb Industries (TSXV:GTII) has been under fire of late.

There’s been some pretty damning allegations highlighting some serious concerns with this stock. That said, the fact this stock has been a four-bagger for investors suggests there’s a lot of momentum behind this name.

Here’s what to make of these allegations.

Intriguing headline-making article spurs conversation

A recent article in the Chicago Tribune spelled out some pretty intriguing allegations.

The article alleged the Illinois-based company is currently being probed for possible wrongdoing in regards to political donations. The investigation centres on reviewing Green Thumb’s campaign donations. Apparently, there’s concern that the cannabis player has been exchanging donations in exchange for access to growing and distribution licences in various states.

As per reports, no charges have been filed against Green Thumb or any member of the management team as of yet. There are no details concerning the timeline or origin of this investigation. Furthermore, it is not clear which federal agency is carrying out the probe.

A spokesperson of Green Thumb Industries revealed that the company was unaware of any ongoing investigation.

Green Thumb denies “baseless” allegations

The company claims that it came to know of this alleged probe through this article. Indeed, no such probe is ongoing, as per Green Thumb’s official press release following the article. Additionally, the company notes that these allegations are baseless.

Furthermore, the CEO and founder of Green Thumb, Ben Kovler, has called out the Chicago Tribune for publishing baseless allegations that are against the corporate values of the company. According to him, the reporter did not mention any credible sources and did not provide any evidence. Therefore, he has demanded the article be retracted.

Indeed, it appears this situation is one investors don’t know what to make of right now. Green Thumb has been a volatile stock of late, and the stock has jumped around on this news.

The company’s management team has fully denounced any wrongdoing and suggests there’s nothing to see here. Additionally, Green Thumb has reassured the investors that this company has secured all its licences via competitive state-specific licensing programs as well as through mergers and acquisitions.

Bottom line

How cannabis companies obtain licences varies in specific jurisdictions. Personally, I don’t quite know what to make of the news.

Indeed, it does appear via the strong response from Green Thumb that investors may have nothing to worry about. However, this is a unique risk that has been brought to investors’ attention right now.

Indeed, for investors in the cannabis space, this appears to be yet another risk to factor into one’s models. That said, in Green Thumb’s case, this may be a non-newsworthy event.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »